What Is Tenet Healthcare Corporation (THC) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Tenet Healthcare Corporation's intrinsic value is estimated at $209.99, presenting a divided outlook at the current price of $194.83. With an average implied return of +7.8% across a split 5–5 (bull–bear) consensus, the model spread of +343.5% underscores analytical uncertainty. Notably, Markov DDM sees the most upside at +262.5% (fair value: $706.35), while Regime Cross is the most conservative at -81.0% ($37.02). The spread between these extremes — +343.5% — reveals how different analytical frameworks can reach starkly different conclusions. Among models with highest confidence, EPV lean bullish — adding weight to the bullish side of the thesis.
What Do the Models Say About THC?
12 of 13 models are currently active for THC. Of these, 6 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates THC's intrinsic value at $60.42, implying -69.0% downside from the current price. See which stocks rank higher →
How Does THC Rank in Services-General Medical & Surgical Hospitals, NEC?
Among 5 Services-General Medical & Surgical Hospitals, NEC stocks, THC ranks #3 by Quality of Company score. CirclFi's QOC score of 8.1/10 evaluates 32 fundamental signals. A score of 8.1 places THC in the top tier.
Tenet Healthcare Corporation operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is THC a Value Trap?
The Value Trap algorithm is not active for THC. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Tenet Healthcare Corporation. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Tenet Healthcare Corporation's fundamental quality profile registers 8.1/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +343.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every THC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across THC's 12 active models, average confidence is 49%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad